Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Neal

Showing results (101-110 of 302) with videos related to

Pageof 31
Sort By:
Cancer Causes & Control : CCC|February 18, 2018
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancerRebecca Gilbert, Kate Tilling, Richard M Martin, et al.
BJU International|September 19, 2006
Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UKLucy A Brindle, Steven E Oliver, Daniel Dedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signalsHayley J Thirkettle, Joanne Girling, Anne Y Warren, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study)Ali S Murad, George Davey Smith, Sarah J Lewis, et al.
Magnetic Resonance in Medicine|March 18, 2011
Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 TeslaMary A McLean, Tristan Barrett, Vincent J Gnanapragasam, et al.
Journal of Clinical Epidemiology|August 19, 2003
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study)Jenny L Donovan, Tim J Peters, Sian Noble, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 8, 2012
Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoringRebecca Gilbert, Chris Metcalfe, William D Fraser, et al.
BMC Health Services Research|June 9, 2023
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Eleanor I Walsh, et al.
International Journal of Cancer|January 9, 2004
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control studySteven E Oliver, David Gunnell, Jenny Donovan, et al.
BJU International|December 21, 2010
First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeonsNaomi Laura Sharma, Alexandros Papadopoulos, Dominic Lee, et al.
Pageof 31

Showing results (101-110 of 302) with videos related to

Sort By:
Pageof 31
Cancer Causes & Control : CCC|February 18, 2018
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancerRebecca Gilbert, Kate Tilling, Richard M Martin, et al.
BJU International|September 19, 2006
Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UKLucy A Brindle, Steven E Oliver, Daniel Dedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signalsHayley J Thirkettle, Joanne Girling, Anne Y Warren, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study)Ali S Murad, George Davey Smith, Sarah J Lewis, et al.
Magnetic Resonance in Medicine|March 18, 2011
Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 TeslaMary A McLean, Tristan Barrett, Vincent J Gnanapragasam, et al.
Journal of Clinical Epidemiology|August 19, 2003
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study)Jenny L Donovan, Tim J Peters, Sian Noble, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 8, 2012
Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoringRebecca Gilbert, Chris Metcalfe, William D Fraser, et al.
BMC Health Services Research|June 9, 2023
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Eleanor I Walsh, et al.
International Journal of Cancer|January 9, 2004
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control studySteven E Oliver, David Gunnell, Jenny Donovan, et al.
BJU International|December 21, 2010
First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeonsNaomi Laura Sharma, Alexandros Papadopoulos, Dominic Lee, et al.
Pageof 31